Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1429-1430
DOI: 10.1111/apt.70628 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-03-17. Written by Yu-Sheng Lin and 2 co-authors. Institution: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 10 references.
Abstract (original language)
Santrauka nepasiekiama.
Subjects
Author keywords
Authors and institutions
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- Genomics Research Center, Academia Sinica, Taipei, Taiwan.
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
ORCID profiles: Teng-Yu Lee
Cite
APA
Lin, Y. S., Yang, H. I., & Lee, T. Y. (2026). Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(10), 1429-1430. https://doi.org/10.1111/apt.70628
Vancouver
Lin YS, Yang HI, Lee TY. Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(10):1429-1430. doi:10.1111/apt.70628
BibTeX
@article{Lin2026,
author = {Lin, Yu-Sheng and Yang, Hwai-I and Lee, Teng-Yu},
title = {Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {10},
pages = {1429--1430},
doi = {10.1111/apt.70628}
}
EUVIMED